Current Liabilities
Accrued Manufacturing Costs
Neurocrine Biosciences Accrued Manufacturing Costs decreased by 36.6% to $81.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.1%, from $57.50M to $81.70M. Over 3 years (FY 2022 to FY 2025), Accrued Manufacturing Costs shows an upward trend with a 20.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2022
Last reportedQ1 2026May 5, 2026
Metric ID:
accrued_manufacturing_costsHistorical Data
12 periods
| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.80M | $68.60M | $86.20M | $42.60M | $59.80M | $77.10M | $107.50M | $57.50M | $84.60M | $105.10M | $128.80M | $81.70M |
| QoQ Change | — | -5.8% | +25.7% | -50.6% | +40.4% | +28.9% | +39.4% | -46.5% | +47.1% | +24.2% | +22.5% | -36.6% |
| YoY Change | — | — | +18.4% | — | — | +12.4% | +24.7% | +35.0% | +41.5% | +36.3% | +19.8% | +42.1% |
Range$42.60M – $128.80M
CAGR+4.3%
Avg YoY Growth+28.8%
Median YoY Growth+29.8%
Accrued Manufacturing Costs at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's accrued manufacturing costs?
- Neurocrine Biosciences (NBIX) reported accrued manufacturing costs of $81.70M in Q1 2026.
- How has Neurocrine Biosciences's accrued manufacturing costs changed year-over-year?
- Neurocrine Biosciences's accrued manufacturing costs increased by 42.1% year-over-year, from $57.50M to $81.70M.
- What is the long-term trend for Neurocrine Biosciences's accrued manufacturing costs?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's accrued manufacturing costs has grown at a 20.9% compound annual growth rate (CAGR), from $72.80M to $128.80M.